Lv11
20 积分 2025-10-02 加入
Real-world survival outcomes of immune checkpoint inhibitor therapy after standard treatment failure in EGFR-mutated NSCLC: A nationwide cohort study
1小时前
已关闭
Relationship between clinicopathological characteristics and PET/CT uptake in lung cancer: [18F]FAPI versus [18F]FDG
1小时前
已完结
Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas
1小时前
已完结
Advances in the treatment of brain metastases in EGFR-mutant non-small cell lung cancer
1小时前
已完结
Unbridled enthusiasm for neoadjuvant chemoimmunotherapy followed by surgery for locally advanced non-small cell lung cancer
2小时前
已完结
皖公网安备34019202002308
